Customization: | Available |
---|---|
Type: | Biochemical Analyzer |
Product Name: | Vet Coagulation Analyzer |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Items | Parameters |
Methodology | Electrochemistry |
Sample Type | Whole blood, Fingertrip blood |
Speed | 8 min/T |
Sample volume | 20ul |
Storage | ≥3000 test |
Print | Bluetooth |
Data Transfer | RS232, 4G, WIFI, Bluetooth |
Incubator | 37.0℃±0.5℃ |
Item | Clinical significance | Anomalies | Causes of disease |
APTT | Reflects normal endogenous coagulation | Raise | Reduced coagulation factors II, VIII, IX, XI, XII, fibrinogen deficiency, enhanced fibrinolytic activity, presence of anticoagulant substances etc. |
Lower | Thrombotic disorders, increased platelets. | ||
PT | Reflects whether exogenous coagulation is normal | Raise | Decreased coagulation factors II, V, VII, X, marked decrease in fibrinogen, increased anticoagulant substances. |
Lower | Most often seen in early DIC, after ether anesthesia, thrombotic disorders, etc. | ||
FIB | Reflects the plasma fibrinogen content to understand the status of coagulation | Raise | Shock, surgery, mild hepatitis, malignant tumors and emergency situations. |
Lower | DIC, primary fibrinolysis, severe hepatitis and cirrhosis congenital low or no FIB blood, hereditary FIB abnormalities. | ||
TT | Fibrinolytic system screening test | Raise | Seen in the presence of increased heparin or heparin-like anticoagulant substances, SLE, DIC, abnormal fibrinogenemia. |
Lower | seen in the presence of calcium ions in the blood or acidic blood, etc. | ||
ACT | Reflects the coagulating time of whole blood | Raise | Overuse of anticoagulant drugs. |
Lower | Inadequate anticoagulation. |